StudyGraphics #VisualAbstract Dupilumab may contribute to ocular surface disease in patients with atopic dermatitis September 10, 2021 | Kathleen Lau Facebook Twitter Pinterest WhatsApp Linkedin ReddIt Email Print RELATED ARTICLESMORE FROM AUTHOR #VisualAbstract Indatuximab ravtansine in combination with immunomodulatory drugs shows objective and clinical response in patients with relapsed or refractory multiple myeloma #VisualAbstract: Perioperative oxiplatin with S-1 significantly improves survival in patients with advanced gastric cancer or gastroesophageal adenocarcinoma undergoing D2 gastrectomy #VisualAbstract: Melanoma survival outcomes have improved between 2003 and 2019 amidst increasing incidence rates
